| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | chromatin binding | 6.68e-04 | 739 | 20 | 5 | GO:0003682 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 1.91e-03 | 65 | 20 | 2 | GO:0004714 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | 1.94e-03 | 938 | 20 | 5 | GO:0016772 | |
| GeneOntologyMolecularFunction | histone binding | 2.23e-03 | 265 | 20 | 3 | GO:0042393 | |
| GeneOntologyMolecularFunction | protein kinase activity | 2.66e-03 | 600 | 20 | 4 | GO:0004672 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 3.24e-03 | 85 | 20 | 2 | GO:0019199 | |
| Domain | - | 6.23e-05 | 73 | 20 | 3 | 2.60.120.260 | |
| Domain | Galactose-bd-like | 1.32e-04 | 94 | 20 | 3 | IPR008979 | |
| Domain | Pkinase_Tyr | 3.37e-04 | 129 | 20 | 3 | PF07714 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 4.10e-04 | 138 | 20 | 3 | IPR001245 | |
| Domain | WW | 1.14e-03 | 47 | 20 | 2 | PF00397 | |
| Domain | WW | 1.19e-03 | 48 | 20 | 2 | SM00456 | |
| Domain | WW_DOMAIN_2 | 1.35e-03 | 51 | 20 | 2 | PS50020 | |
| Domain | WW_DOMAIN_1 | 1.35e-03 | 51 | 20 | 2 | PS01159 | |
| Domain | WW_dom | 1.40e-03 | 52 | 20 | 2 | IPR001202 | |
| Domain | - | 1.68e-03 | 57 | 20 | 2 | 3.30.50.10 | |
| Domain | Znf_NHR/GATA | 1.74e-03 | 58 | 20 | 2 | IPR013088 | |
| Domain | TyrKc | 3.95e-03 | 88 | 20 | 2 | SM00219 | |
| Domain | Tyr_kinase_cat_dom | 3.95e-03 | 88 | 20 | 2 | IPR020635 | |
| Domain | PROTEIN_KINASE_TYR | 4.77e-03 | 97 | 20 | 2 | PS00109 | |
| Domain | Tyr_kinase_AS | 4.77e-03 | 97 | 20 | 2 | IPR008266 | |
| Domain | Prot_kinase_dom | 1.46e-02 | 489 | 20 | 3 | IPR000719 | |
| Pubmed | Adam22 is a major neuronal receptor for Lgi4-mediated Schwann cell signaling. | 1.13e-05 | 9 | 20 | 2 | 20220021 | |
| Pubmed | 5.93e-05 | 20 | 20 | 2 | 21068328 | ||
| Pubmed | 1.18e-04 | 28 | 20 | 2 | 18593464 | ||
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | 1.90e-04 | 197 | 20 | 3 | 20811636 | |
| Pubmed | 2.42e-04 | 40 | 20 | 2 | 26297811 | ||
| Pubmed | 2.42e-04 | 40 | 20 | 2 | 28805822 | ||
| Pubmed | Common genetic variation and the control of HIV-1 in humans. | 2.42e-04 | 40 | 20 | 2 | 20041166 | |
| Pubmed | 2.42e-04 | 40 | 20 | 2 | 30898150 | ||
| Pubmed | 3.49e-04 | 48 | 20 | 2 | 20301532 | ||
| Pubmed | 3.50e-04 | 1116 | 20 | 5 | 31753913 | ||
| Interaction | MCRS1 interactions | 7.54e-05 | 235 | 20 | 4 | int:MCRS1 | |
| Interaction | MED30 interactions | 7.57e-05 | 84 | 20 | 3 | int:MED30 | |
| Interaction | MED29 interactions | 1.35e-04 | 102 | 20 | 3 | int:MED29 | |
| Interaction | MED19 interactions | 1.51e-04 | 106 | 20 | 3 | int:MED19 | |
| Interaction | MED26 interactions | 1.55e-04 | 107 | 20 | 3 | int:MED26 | |
| Interaction | RBBP5 interactions | 1.63e-04 | 287 | 20 | 4 | int:RBBP5 | |
| Cytoband | 6p21.3 | 5.26e-03 | 250 | 20 | 2 | 6p21.3 | |
| Coexpression | GSE22886_CD8_TCELL_VS_BCELL_NAIVE_DN | 1.39e-05 | 198 | 20 | 4 | M4429 | |
| Coexpression | KAECH_NAIVE_VS_DAY8_EFF_CD8_TCELL_UP | 1.45e-05 | 200 | 20 | 4 | M3012 | |
| Coexpression | GAUTAM_EYE_IRIS_CILIARY_BODY_CRYAA_HIGH_CILIARY_BODY_CELLS | 3.24e-05 | 82 | 20 | 3 | M43626 | |
| Coexpression | HOLLERN_EMT_BREAST_TUMOR_DN | 1.08e-04 | 123 | 20 | 3 | M624 | |
| Coexpression | HOLLERN_EMT_BREAST_TUMOR_DN | 1.43e-04 | 135 | 20 | 3 | MM965 | |
| Coexpression | ZHONG_PFC_C3_ASTROCYTE | 1.92e-04 | 389 | 20 | 4 | M39102 | |
| Coexpression | LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2 | 3.12e-04 | 176 | 20 | 3 | M39223 | |
| Coexpression | GSE17301_IFNA2_VS_IFNA5_STIM_ACD3_ACD28_ACT_CD8_TCELL_UP | 4.40e-04 | 198 | 20 | 3 | M8036 | |
| Coexpression | GSE11057_NAIVE_VS_EFF_MEMORY_CD4_TCELL_UP | 4.40e-04 | 198 | 20 | 3 | M3104 | |
| Coexpression | GSE43955_1H_VS_60H_ACT_CD4_TCELL_DN | 4.47e-04 | 199 | 20 | 3 | M9651 | |
| Coexpression | GSE20715_0H_VS_24H_OZONE_TLR4_KO_LUNG_UP | 4.47e-04 | 199 | 20 | 3 | M4374 | |
| Coexpression | GSE360_L_MAJOR_VS_M_TUBERCULOSIS_DC_DN | 4.47e-04 | 199 | 20 | 3 | M5214 | |
| Coexpression | GSE45739_UNSTIM_VS_ACD3_ACD28_STIM_WT_CD4_TCELL_UP | 4.53e-04 | 200 | 20 | 3 | M9886 | |
| Coexpression | GSE8921_3H_VS_24H_TLR1_2_STIM_MONOCYTE_UP | 4.53e-04 | 200 | 20 | 3 | M6424 | |
| Coexpression | GSE23502_BM_VS_COLON_TUMOR_MYELOID_DERIVED_SUPPRESSOR_CELL_UP | 4.53e-04 | 200 | 20 | 3 | M8087 | |
| Coexpression | GSE12392_IFNAR_KO_VS_IFNB_KO_CD8_NEG_SPLEEN_DC_DN | 4.53e-04 | 200 | 20 | 3 | M7136 | |
| Coexpression | GSE17721_PAM3CSK4_VS_GADIQUIMOD_1H_BMDC_UP | 4.53e-04 | 200 | 20 | 3 | M3962 | |
| Coexpression | GSE39110_UNTREATED_VS_IL2_TREATED_CD8_TCELL_DAY6_POST_IMMUNIZATION_DN | 4.53e-04 | 200 | 20 | 3 | M9285 | |
| Coexpression | GSE22886_NAIVE_BCELL_VS_BM_PLASMA_CELL_UP | 4.53e-04 | 200 | 20 | 3 | M4442 | |
| Coexpression | GSE360_CTRL_VS_M_TUBERCULOSIS_DC_UP | 4.53e-04 | 200 | 20 | 3 | M5154 | |
| Coexpression | KAECH_NAIVE_VS_MEMORY_CD8_TCELL_UP | 4.53e-04 | 200 | 20 | 3 | M3020 | |
| Coexpression | GOLDRATH_EFF_VS_MEMORY_CD8_TCELL_DN | 4.53e-04 | 200 | 20 | 3 | M3044 | |
| Coexpression | GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_UP | 4.53e-04 | 200 | 20 | 3 | M5229 | |
| Coexpression | BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A | 4.74e-04 | 899 | 20 | 5 | M2242 | |
| Coexpression | BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A | 5.53e-04 | 930 | 20 | 5 | MM893 | |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | 6.06e-04 | 221 | 20 | 3 | M39222 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_naive-4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.97e-05 | 172 | 20 | 3 | 62ed3b70fa1f6c84ea80ff00f60d2562be292e9d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.77e-05 | 188 | 20 | 3 | d8decd9b5967873ca8320c2f9f07365f163c777f | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 7.89e-05 | 189 | 20 | 3 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3_mon|organoid_Paulsen_bioRxiv / Sample Type, Dataset, Time_group, and Cell type. | 8.53e-05 | 194 | 20 | 3 | 4903a0d6e36599bcb83b179462e5b949df9eb685 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.53e-05 | 194 | 20 | 3 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.66e-05 | 195 | 20 | 3 | 6477e6e7be5bd8eb99119a12ae16334ccddecd43 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.66e-05 | 195 | 20 | 3 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.79e-05 | 196 | 20 | 3 | eea66711a16134f86e6c533a5a837ff2e0d7ca7f | |
| ToppCell | mild-B_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.33e-05 | 200 | 20 | 3 | 222789b897e2a683bbfd1d00b6fd8705015d90df | |
| ToppCell | mild-B_naive|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.33e-05 | 200 | 20 | 3 | d0467cab6a42bf780aa49046bf3231ca161dc144 | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th-Inhibitory_Neuron.Gad1Gad2-Th.Trh_(Th+_interneuron)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 6.56e-04 | 85 | 20 | 2 | 86c5d71b66ff55c44d2d457865dda72e07e5ec53 | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th-Inhibitory_Neuron.Gad1Gad2-Th.Trh_(Th+_interneuron)|Striatum / BrainAtlas - Mouse McCarroll V32 | 6.56e-04 | 85 | 20 | 2 | 67336aa7ec02b64595ce7d5222d43cead92eb52e | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th|Striatum / BrainAtlas - Mouse McCarroll V32 | 6.56e-04 | 85 | 20 | 2 | a7a5d82924cd4a41ab87b1abf13143635882a4b2 | |
| ToppCell | Posterior_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 7.51e-04 | 91 | 20 | 2 | 7a60989eeb495e42e72e6d5d403e8d34027f9bd0 | |
| ToppCell | Posterior_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Acta2Rgs5Rgs5_(Mural.Acta2Rgs5Rgs5)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 7.51e-04 | 91 | 20 | 2 | 8f072b10386ef2742e7f95dcfbc42bfacf2af5f1 | |
| ToppCell | Posterior_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Acta2Rgs5Rgs5_(Mural.Acta2Rgs5Rgs5)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 7.51e-04 | 91 | 20 | 2 | b576c4ab6ec2f80682dd51dc72dde35f99b1c7eb | |
| ToppCell | Substantia_nigra-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Rgs5Acta2.Cbr2_(Mural.Rgs5Acta2.Cbr2)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 8.87e-04 | 99 | 20 | 2 | 0e2f6ba2261cc289f8f4aec5aac3051f6321e041 | |
| ToppCell | Substantia_nigra-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Rgs5Acta2.Cbr2_(Mural.Rgs5Acta2.Cbr2)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 8.87e-04 | 99 | 20 | 2 | ce9d6d9b82bdc1ebb58b0b6e04abfb022dd1de88 | |
| ToppCell | Substantia_nigra-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Rgs5Acta2.Fos_(Mural.Rgs5Acta2.Fos)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 9.97e-04 | 105 | 20 | 2 | 73639bfa677c7bb9e5166aa09eabaf1b05bb89a0 | |
| ToppCell | Substantia_nigra-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Rgs5Acta2.Fos_(Mural.Rgs5Acta2.Fos)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 9.97e-04 | 105 | 20 | 2 | 84b639eb44f71d1e12bb7850b9063d80e73cb741 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Airway|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.39e-03 | 124 | 20 | 2 | d88bce8a4f023d5b617b2e8e372a94bd1248d20d | |
| ToppCell | Substantia_nigra-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.45e-03 | 127 | 20 | 2 | 8c972ea21797ee46d6c67e91cfd2e2e2ce016248 | |
| ToppCell | Cerebellum-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Nrgn_(Inferior_colliculus)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.48e-03 | 128 | 20 | 2 | 9a800beca5cfc7b41f5eed500d45064cfa61c5de | |
| ToppCell | Cerebellum-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Nrgn_(Inferior_colliculus)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.48e-03 | 128 | 20 | 2 | 920ede29f3de68e4d08644a1da53849e0c0973fb | |
| ToppCell | LV-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.52e-03 | 130 | 20 | 2 | a3e12984fb61311e49cc76c59f74f4dffc48faa1 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.59e-03 | 133 | 20 | 2 | 5bf5e654653e2c340891f51e3f2a30441b7b6b2b | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Intermediate_Fibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.69e-03 | 137 | 20 | 2 | dd5364a1002650d21e0c83d8c701b5f7b09d1c19 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-unknown_epithelial|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.69e-03 | 137 | 20 | 2 | 03e124901a0e85b59b6882bbafab568b50907e8b | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 1.71e-03 | 138 | 20 | 2 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | tumor_Lung-T/NK_cells-CD8_low_T|T/NK_cells / Location, Cell class and cell subclass | 1.81e-03 | 142 | 20 | 2 | eaf08a0dbacc9ebbd54e377922e76d8ba854dcb8 | |
| ToppCell | Mild/Remission-B_naive-1|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.84e-03 | 143 | 20 | 2 | bd3f5fbd4e9e4dc414682db5607494f3ce988deb | |
| ToppCell | Control-Myeloid-Dendritic_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.84e-03 | 143 | 20 | 2 | bb8d4c335682d1a6798bed0de8bb0603054a4944 | |
| ToppCell | severe_COVID-19-B_cell|World / disease group, cell group and cell class (v2) | 1.84e-03 | 143 | 20 | 2 | 28b0e168126a9fe60541dc12bfab385b7a0a2342 | |
| ToppCell | severe_COVID-19-B_cell|severe_COVID-19 / disease group, cell group and cell class (v2) | 1.86e-03 | 144 | 20 | 2 | c7f696e55e2d959c58ec32640c71ef86ee25203c | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Nptxr|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.96e-03 | 148 | 20 | 2 | 223d6a640f3c34e73646a615593b9c0b4a4cbd6f | |
| ToppCell | Mild/Remission-B_naive-4|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.96e-03 | 148 | 20 | 2 | dd5e1bc02824e743e1c030a303e32f27a359a8ca | |
| ToppCell | PND01-03-samps-Epithelial-Alveolar_epithelial-AT1_-_meso|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 2.02e-03 | 150 | 20 | 2 | 6a13e4c4b9c9e54a5016573a37132465ec1c8f99 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 2.04e-03 | 151 | 20 | 2 | 999c11d19b61d6b130ad5e623afa83cbdfe13cdd | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-03 | 152 | 20 | 2 | 7e686721b95c837f2b0d5116927c8ecacef055ee | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.10e-03 | 153 | 20 | 2 | e7a074ea8232bacf924be78a244a8507c7e1ebc8 | |
| ToppCell | Influenza_Severe-Treg|Influenza_Severe / Disease group and Cell class | 2.12e-03 | 154 | 20 | 2 | 77845bcb243aa1b1f1ca00f9ef2ae1b4d1bd3696 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_naive-5|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.12e-03 | 154 | 20 | 2 | 020697ae8463b18f9b4270c404f52ce4c0e90135 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-03 | 154 | 20 | 2 | 1e32969bee810adaf2d560f0824a16227df513d8 | |
| ToppCell | Severe-B_naive-1|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.26e-03 | 159 | 20 | 2 | 2881b054bbeb479221ee3c38bbd9b0815b123579 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.26e-03 | 159 | 20 | 2 | 1baf0eaf9684668146a63192e77eec6c3c7a37f8 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-03 | 159 | 20 | 2 | 323cb4a2416d2e6bff0a3f225d2edeae9ab7dc76 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell-Schwann_Cell_/_Neural|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.29e-03 | 160 | 20 | 2 | 14dfa519e68bab4bce890ddb66fa7763f18d9f19 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Neural|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.29e-03 | 160 | 20 | 2 | 5b7789d4668ed7732babedc32d812233b430e0bd | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell-Schwann_Cell_/_Neural-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.29e-03 | 160 | 20 | 2 | bba1486faaad5299e10f4fe17c6d149c28dc2560 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.29e-03 | 160 | 20 | 2 | 839bbdfd4e4c7b48260c8bfb7670378634405e1d | |
| ToppCell | COVID-CD8-CD8_2|COVID / Condition, Cell_class and T cell subcluster | 2.32e-03 | 161 | 20 | 2 | 307dcc17475413cd9eb70c27bc447f938ee5723d | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.32e-03 | 161 | 20 | 2 | 2d63b279d9a5132e1c09b03930bf9039036d24a2 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.35e-03 | 162 | 20 | 2 | ec29c6f1c31e41ddcb041a49c593910edaf0532c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural-neural_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.35e-03 | 162 | 20 | 2 | d28b2ea1d2c8f3c6a107991573471b6d0c49c4ae | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.35e-03 | 162 | 20 | 2 | 5bbd7130d4dad9035e73a439dda568195c136f31 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.35e-03 | 162 | 20 | 2 | eed223e61c8162a2fe004ab4e09de5e037be7553 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.35e-03 | 162 | 20 | 2 | e35ddce830e20ebeac1a2c405293fc4a5323dd4a | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.37e-03 | 163 | 20 | 2 | 0ab043b68e8739adcedda01165a3758cd0d22728 | |
| ToppCell | facs-Lung-EPCAM-24m-Myeloid-lung_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-03 | 164 | 20 | 2 | 4e0133a7f80cf6bd3d70f72ee26360df5f80ab32 | |
| ToppCell | facs-Lung-EPCAM-24m-Myeloid-Interstitial_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-03 | 164 | 20 | 2 | 4ab1a7d5379a633c3f61af1c8c2df93b6961d9cf | |
| ToppCell | E15.5-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.43e-03 | 165 | 20 | 2 | 8d3d5860a4785c4908160ae5fcb421ee80bd78ce | |
| ToppCell | E15.5-Endothelial-lymphatic_endothelial_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.43e-03 | 165 | 20 | 2 | 17ee6f269ed8d378465cf00ca59d48d8b106808e | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.43e-03 | 165 | 20 | 2 | fead3f2032f8fa5f7f0159a4434989b3d65debbb | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-interstitial_macrophage-interstitial_macrophage_l12|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.46e-03 | 166 | 20 | 2 | 7be2b5c62e2be3437ea50b9a473cf9fc7f05e0b1 | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-interstitial_macrophage|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.46e-03 | 166 | 20 | 2 | 8418b191e7f16cb39301df3ddbfb1bab6c0632d6 | |
| ToppCell | COVID-19_Severe-CD4+_T_activated|COVID-19_Severe / Disease condition and Cell class | 2.46e-03 | 166 | 20 | 2 | 0f138dbafad6f83975944e8f6398411127b150cc | |
| ToppCell | severe-CD4+_T_naive|severe / disease stage, cell group and cell class | 2.49e-03 | 167 | 20 | 2 | 02a8215fca59c357c1cdaa5738849eacf98c0bcc | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-03 | 168 | 20 | 2 | 0e8b0e6399c6c82c9c0e546f7316f902de0765d3 | |
| ToppCell | P28-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.52e-03 | 168 | 20 | 2 | 8c8dbdbc7053f34e4ca0c5067af502fbea109fc1 | |
| ToppCell | COVID-19-Heart-Neuronal|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.52e-03 | 168 | 20 | 2 | 88c2c574f428c2502b5fe099bd73b0758f668ef6 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.55e-03 | 169 | 20 | 2 | cfc9ff103d13a2d5eacc457e800f53fdd29f7738 | |
| ToppCell | Mild/Remission-B_naive-4|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.55e-03 | 169 | 20 | 2 | c3a6179a64589a370108fea809b157839347759c | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.55e-03 | 169 | 20 | 2 | b2fdf9f842dc7c181bc951a8a6932c916ed835ef | |
| ToppCell | Control-Mast_cells|Control / group, cell type (main and fine annotations) | 2.55e-03 | 169 | 20 | 2 | fdb9abca1d0f4fdc32dd8ac6231651ef34aa5afb | |
| ToppCell | PND10-Immune-Immune_Myeloid-DC-maDC-maDC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.55e-03 | 169 | 20 | 2 | a83e4078db91ecedee637b28b12ec38640fe45f9 | |
| ToppCell | PND10-Immune-Immune_Myeloid-DC-maDC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.55e-03 | 169 | 20 | 2 | f914aa8899fa170a09da31e5fad86de897ea789b | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.55e-03 | 169 | 20 | 2 | 2322f03a115c662f808ebfc892192b7d38d48181 | |
| ToppCell | COVID-19_Mild-PLT_2|World / Disease Group and Platelet Clusters | 2.55e-03 | 169 | 20 | 2 | 6abfdc8b437f19c03b408bedc245059d28c6ba6a | |
| ToppCell | Control-Mast_cells-Mast_cells|Control / group, cell type (main and fine annotations) | 2.58e-03 | 170 | 20 | 2 | c80f6d29096c372da95a8407f402349ff1bb7018 | |
| ToppCell | P07-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.64e-03 | 172 | 20 | 2 | 8d6a2a0d5f63b09a5a304a77e600a647f87e9de4 | |
| ToppCell | Immune_cells-B_cell|Immune_cells / Lineage and Cell class | 2.64e-03 | 172 | 20 | 2 | b646894b691a99bf2742bd9da8e578dff0e87f1f | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.64e-03 | 172 | 20 | 2 | 30916a902c151907745756d14327e24adc34afef | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-03 | 173 | 20 | 2 | d78397e65e997ddb995111a810f0e2a4f67d0765 | |
| ToppCell | COVID-19_Mild-PLT_2|COVID-19_Mild / Disease Group and Platelet Clusters | 2.67e-03 | 173 | 20 | 2 | d11705e56b6b21eec963ea224717f27680c781ed | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-03 | 173 | 20 | 2 | 3c852ffe22f4a5b632463086b08c669310684e80 | |
| ToppCell | wk_20-22-Epithelial-PNS|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.67e-03 | 173 | 20 | 2 | 17b1a6b0318925d5d920f2c0a791745b9587ebef | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.70e-03 | 174 | 20 | 2 | 1463c98f8f519dd030587abbdbeb1b4e1bca5dd1 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Neuronal-Glial_immature|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.70e-03 | 174 | 20 | 2 | c9d4e375dedd2b099a9ed70ec38ff35bbb0ce48a | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Neuronal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.70e-03 | 174 | 20 | 2 | d421c0069d24cb560a3a429929e3cd1eceaeabcf | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.70e-03 | 174 | 20 | 2 | 667035a11b68745fa8446d6c68214713be42710f | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L5-6_FEZF2_ANKRD20A1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.70e-03 | 174 | 20 | 2 | 99eb5e1aee136c7039e23b68a43a0fa3d775859f | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.73e-03 | 175 | 20 | 2 | 442f261a3b2c4d2523f7d4089178f8c79cac2f0f | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-03 | 175 | 20 | 2 | 31f0fb2e47e357dbf9c15436b7df85b3c370ded7 | |
| ToppCell | facs|World / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-03 | 175 | 20 | 2 | 53e96956019f984decc1c81376ebc88fbf3c4d40 | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.73e-03 | 175 | 20 | 2 | 35fb7735dd3355476fe60404833cb60bd066bcf1 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-B_cells-Naive_B|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.73e-03 | 175 | 20 | 2 | d544f24ee33783ed4afb4d7ec079a4484118bb15 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.73e-03 | 175 | 20 | 2 | 21f8f11a8b874d4f7c47931010a2535f2a5a3373 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.73e-03 | 175 | 20 | 2 | ff0789f5913c9f3c49159e40b1ec3d2ff175ec9f | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.76e-03 | 176 | 20 | 2 | ad05dd934f4ac2e656b3455de091f4c8772de6c8 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_D3|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.76e-03 | 176 | 20 | 2 | bd5c85b3a4fb88ffe156599f6d224aa7664a513a | |
| Drug | Methiazole; Down 200; 15uM; PC3; HT_HG-U133A | 6.43e-07 | 197 | 20 | 5 | 4532_DN | |
| Drug | Diprophylline [479-18-5]; Up 200; 15.8uM; MCF7; HT_HG-U133A | 6.43e-07 | 197 | 20 | 5 | 5482_UP | |
| Drug | Convolamine hydrochloride [500-56-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 6.59e-07 | 198 | 20 | 5 | 2771_DN | |
| Drug | Guaifenesin [93-14-1]; Down 200; 20.2uM; PC3; HT_HG-U133A | 2.18e-05 | 193 | 20 | 4 | 3814_DN | |
| Drug | Metampicillin sodium salt [6489-61-8]; Up 200; 10.4uM; PC3; HT_HG-U133A | 2.27e-05 | 195 | 20 | 4 | 5115_UP | |
| Drug | Dipyrone [5907-38-0]; Down 200; 12uM; MCF7; HT_HG-U133A | 2.27e-05 | 195 | 20 | 4 | 3835_DN | |
| Drug | Cefaclor [70356-03-5]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 2.32e-05 | 196 | 20 | 4 | 2843_DN | |
| Drug | Meclofenamic acid sodium salt monohydrate [6385-02-0]; Down 200; 11.8uM; HL60; HG-U133A | 2.32e-05 | 196 | 20 | 4 | 1445_DN | |
| Drug | Meclozine dihydrochloride [1104-22-9]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 2.36e-05 | 197 | 20 | 4 | 5244_DN | |
| Drug | Denatonium benzoate [3734-33-6]; Up 200; 9uM; MCF7; HT_HG-U133A | 2.36e-05 | 197 | 20 | 4 | 5480_UP | |
| Drug | Vincamine [1617-90-9]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 2.36e-05 | 197 | 20 | 4 | 3865_DN | |
| Drug | Picotamide monohydrate [80530-63-8]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 2.36e-05 | 197 | 20 | 4 | 6787_DN | |
| Drug | (-)-MK 801 hydrogen maleate [77086-19-2]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 2.41e-05 | 198 | 20 | 4 | 6458_UP | |
| Drug | LY 294002; Up 200; 0.1uM; MCF7; HT_HG-U133A | 2.41e-05 | 198 | 20 | 4 | 6976_UP | |
| Drug | (1-[(4-Chlorophenyl)phenyl-methyl]-4-methylpiperazine) [1620-21-9]; Up 200; 11.8uM; HL60; HT_HG-U133A | 2.41e-05 | 198 | 20 | 4 | 2197_UP | |
| Drug | Guaifenesin [93-14-1]; Down 200; 20.2uM; MCF7; HT_HG-U133A | 2.41e-05 | 198 | 20 | 4 | 3897_DN | |
| Drug | 0173570-0000 [211245-44-2]; Up 200; 1uM; PC3; HT_HG-U133A | 2.41e-05 | 198 | 20 | 4 | 7391_UP | |
| Drug | Glycocholic acid [475-31-0]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 2.41e-05 | 198 | 20 | 4 | 5316_UP | |
| Drug | catechin; Down 200; 11uM; MCF7; HT_HG-U133A_EA | 2.41e-05 | 198 | 20 | 4 | 1101_DN | |
| Drug | Danazol [17230-88-5]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 2.41e-05 | 198 | 20 | 4 | 1538_UP | |
| Drug | Lisinopril [83915-83-7]; Up 200; 9uM; MCF7; HT_HG-U133A | 2.46e-05 | 199 | 20 | 4 | 5504_UP | |
| Drug | Letrozole [112809-51-5]; Up 200; 14uM; MCF7; HT_HG-U133A | 2.46e-05 | 199 | 20 | 4 | 7336_UP | |
| Drug | Denatonium benzoate [3734-33-6]; Up 200; 9uM; MCF7; HT_HG-U133A | 2.51e-05 | 200 | 20 | 4 | 6502_UP | |
| Drug | Speract | 2.00e-04 | 24 | 20 | 2 | CID000123688 | |
| Drug | DL-arginine | 2.05e-04 | 344 | 20 | 4 | CID000000232 | |
| Drug | indigo carmine | 2.17e-04 | 25 | 20 | 2 | CID005282429 | |
| Drug | copper complex | 2.35e-04 | 26 | 20 | 2 | CID000410253 | |
| Drug | I vs | 2.77e-04 | 147 | 20 | 3 | CID000444340 | |
| Drug | iodomelatonin | 3.14e-04 | 30 | 20 | 2 | CID000115348 | |
| Drug | AC1L1K7W | 4.04e-04 | 34 | 20 | 2 | CID000005377 | |
| Drug | Metaproterenol sulfate, orciprenaline sulfate [5874-97-5]; Up 200; 7.6uM; PC3; HT_HG-U133A | 4.94e-04 | 179 | 20 | 3 | 4248_UP | |
| Drug | Rolitetracycline [751-97-3]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 5.43e-04 | 185 | 20 | 3 | 3369_DN | |
| Drug | fluphenazine dihydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A | 5.52e-04 | 186 | 20 | 3 | 6996_UP | |
| Drug | ICI 182,780; Down 200; 0.01uM; MCF7; HT_HG-U133A | 5.61e-04 | 187 | 20 | 3 | 5598_DN | |
| Drug | Terfenadine [50679-08-8]; Down 200; 8.4uM; HL60; HG-U133A | 5.78e-04 | 189 | 20 | 3 | 1381_DN | |
| Drug | Econazole nitrate [24169-02-6]; Up 200; 9uM; PC3; HT_HG-U133A | 5.87e-04 | 190 | 20 | 3 | 7305_UP | |
| Drug | YC-1 compound | 5.89e-04 | 41 | 20 | 2 | CID000005712 | |
| Drug | Terfenadine [50679-08-8]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 5.96e-04 | 191 | 20 | 3 | 2227_DN | |
| Drug | Betamethasone [378-44-9]; Up 200; 10.2uM; PC3; HT_HG-U133A | 6.05e-04 | 192 | 20 | 3 | 6728_UP | |
| Drug | Metampicillin sodium salt [6489-61-8]; Up 200; 10.4uM; PC3; HT_HG-U133A | 6.05e-04 | 192 | 20 | 3 | 2123_UP | |
| Drug | Etofenamate [30544-47-9]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 6.05e-04 | 192 | 20 | 3 | 4108_UP | |
| Drug | Epitiostanol [2363-58-8]; Up 200; 13uM; MCF7; HT_HG-U133A | 6.15e-04 | 193 | 20 | 3 | 4788_UP | |
| Drug | Tolazamide [1156-19-0]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 6.15e-04 | 193 | 20 | 3 | 2842_UP | |
| Drug | Captopril [62571-86-2]; Up 200; 17.2uM; HL60; HG-U133A | 6.15e-04 | 193 | 20 | 3 | 1988_UP | |
| Drug | Methylhydantoin-5-(L) [40856-73-3]; Down 200; 35uM; MCF7; HT_HG-U133A | 6.15e-04 | 193 | 20 | 3 | 3378_DN | |
| Drug | Fenoprofen calcium salt dihydrate [53746-45-5]; Down 200; 7.2uM; MCF7; HT_HG-U133A | 6.15e-04 | 193 | 20 | 3 | 3412_DN | |
| Drug | Chlorpheniramine maleate [113-92-8]; Up 200; 10.2uM; PC3; HT_HG-U133A | 6.15e-04 | 193 | 20 | 3 | 2055_UP | |
| Drug | Cefazolin sodium salt [27164-46-1]; Up 200; 8.4uM; PC3; HT_HG-U133A | 6.15e-04 | 193 | 20 | 3 | 7385_UP | |
| Drug | Karakoline [39089-30-0]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 6.24e-04 | 194 | 20 | 3 | 4763_DN | |
| Drug | Dosulepin hydrochloride [897-15-4]; Down 200; 12uM; MCF7; HT_HG-U133A | 6.24e-04 | 194 | 20 | 3 | 2864_DN | |
| Drug | PF-00875133-00 [351322-64-0]; Up 200; 10uM; MCF7; HT_HG-U133A | 6.24e-04 | 194 | 20 | 3 | 5923_UP | |
| Drug | Acyclovir [59277-89-3]; Down 200; 17.8uM; MCF7; HT_HG-U133A | 6.24e-04 | 194 | 20 | 3 | 5278_DN | |
| Drug | Verapamyl hydrochloride [152-11-4]; Down 200; 8.2uM; HL60; HG-U133A | 6.24e-04 | 194 | 20 | 3 | 2009_DN | |
| Drug | Pindolol [13523-86-9]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 6.24e-04 | 194 | 20 | 3 | 2238_DN | |
| Drug | Sertaconazole nitrate [99592-39-9]; Down 200; 8uM; MCF7; HT_HG-U133A | 6.24e-04 | 194 | 20 | 3 | 6811_DN | |
| Drug | Etifenin [63245-28-3]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 6.24e-04 | 194 | 20 | 3 | 4117_UP | |
| Drug | 2-propylpentanoic acid; Down 200; 50uM; HL60; HT_HG-U133A | 6.33e-04 | 195 | 20 | 3 | 1163_DN | |
| Drug | Acenocoumarol [152-72-7]; Up 200; 11.4uM; PC3; HT_HG-U133A | 6.33e-04 | 195 | 20 | 3 | 5878_UP | |
| Drug | Fluspirilen [1841-19-6]; Up 200; 8.4uM; PC3; HT_HG-U133A | 6.33e-04 | 195 | 20 | 3 | 6662_UP | |
| Drug | Butoconazole nitrate [32872-77-1]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 6.33e-04 | 195 | 20 | 3 | 5388_DN | |
| Drug | Flurandrenolide [1524-88-5]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 6.33e-04 | 195 | 20 | 3 | 6039_UP | |
| Drug | Alfaxalone [23930-19-0]; Up 200; 12uM; MCF7; HT_HG-U133A | 6.33e-04 | 195 | 20 | 3 | 5451_UP | |
| Drug | Ethynylestradiol 3-methyl ether [72-33-3]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 6.33e-04 | 195 | 20 | 3 | 4792_UP | |
| Drug | Sulfamerazine [127-79-7]; Down 200; 15.2uM; MCF7; HT_HG-U133A | 6.33e-04 | 195 | 20 | 3 | 4740_DN | |
| Drug | Methoxy-8-psoralen [298-81-7]; Down 200; 18.6uM; PC3; HT_HG-U133A | 6.33e-04 | 195 | 20 | 3 | 6661_DN | |
| Drug | Myricetin [529-44-2]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 6.33e-04 | 195 | 20 | 3 | 4170_DN | |
| Drug | Proglumide [6620-60-6]; Down 200; 12uM; MCF7; HT_HG-U133A | 6.33e-04 | 195 | 20 | 3 | 3972_DN | |
| Drug | Quinidine hydrochloride monohydrate [6151-40-2]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 6.33e-04 | 195 | 20 | 3 | 3191_DN | |
| Drug | SC 19220; Up 200; 10uM; MCF7; HT_HG-U133A | 6.33e-04 | 195 | 20 | 3 | 7060_UP | |
| Drug | 17-AAG; Up 200; 1uM; ssMCF7; HG-U133A | 6.33e-04 | 195 | 20 | 3 | 521_UP | |
| Drug | Promazine hydrochloride [53-60-1]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 6.43e-04 | 196 | 20 | 3 | 6028_DN | |
| Drug | (S)-(-)-Cycloserine [339-72-0]; Down 200; 39.2uM; PC3; HT_HG-U133A | 6.43e-04 | 196 | 20 | 3 | 3789_DN | |
| Drug | Flutamide [13311-84-7]; Down 200; 14.4uM; PC3; HT_HG-U133A | 6.43e-04 | 196 | 20 | 3 | 4539_DN | |
| Drug | Deferoxamine mesylate [138-14-7]; Down 200; 6uM; MCF7; HT_HG-U133A | 6.43e-04 | 196 | 20 | 3 | 3842_DN | |
| Drug | Demecarium bromide [56-94-0]; Up 200; 5.6uM; MCF7; HT_HG-U133A | 6.43e-04 | 196 | 20 | 3 | 6269_UP | |
| Drug | Iopamidol [60166-93-0]; Up 200; 5.2uM; MCF7; HT_HG-U133A | 6.43e-04 | 196 | 20 | 3 | 3473_UP | |
| Drug | valinomycin; Down 200; 0.1uM; PC3; HT_HG-U133A | 6.43e-04 | 196 | 20 | 3 | 5962_DN | |
| Drug | Hexamethonium dibromide dihydrate [55-97-0]; Up 200; 10uM; MCF7; HT_HG-U133A | 6.43e-04 | 196 | 20 | 3 | 4965_UP | |
| Drug | Nomegestrol acetate [58652-20-3]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 6.43e-04 | 196 | 20 | 3 | 5461_UP | |
| Drug | Fenofibrate [49562-28-9]; Up 200; 11uM; MCF7; HT_HG-U133A | 6.43e-04 | 196 | 20 | 3 | 7432_UP | |
| Drug | Labetalol hydrochloride [32780-64-6]; Down 200; 11uM; MCF7; HT_HG-U133A | 6.43e-04 | 196 | 20 | 3 | 3167_DN | |
| Drug | Heliotrine [303-33-3]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 6.43e-04 | 196 | 20 | 3 | 4739_DN | |
| Drug | Practolol [6673-35-4]; Up 200; 15uM; MCF7; HT_HG-U133A | 6.43e-04 | 196 | 20 | 3 | 3204_UP | |
| Drug | Guanadrel sulfate [22195-34-2]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 6.43e-04 | 196 | 20 | 3 | 4720_UP | |
| Drug | Metrizamide [31112-62-6]; Down 200; 5uM; MCF7; HT_HG-U133A | 6.43e-04 | 196 | 20 | 3 | 3255_DN | |
| Drug | Proguanil hydrochloride [637-32-1]; Down 200; 13.8uM; HL60; HT_HG-U133A | 6.43e-04 | 196 | 20 | 3 | 2944_DN | |
| Drug | Nalidixic acid sodium salt hydrate; Up 200; 14.6uM; PC3; HT_HG-U133A | 6.43e-04 | 196 | 20 | 3 | 3668_UP | |
| Drug | Tenoxicam [59804-37-4]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 6.43e-04 | 196 | 20 | 3 | 4182_DN | |
| Drug | Nialamide [51-12-7]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 6.43e-04 | 196 | 20 | 3 | 4347_UP | |
| Drug | Hemicholinium bromide [312-45-8]; Up 200; 7uM; MCF7; HT_HG-U133A | 6.43e-04 | 196 | 20 | 3 | 5339_UP | |
| Drug | Cinchonine [118-10-5]; Up 200; 13.6uM; HL60; HT_HG-U133A | 6.43e-04 | 196 | 20 | 3 | 2133_UP | |
| Drug | Methyldopa (L,-) [555-30-6]; Up 200; 19uM; MCF7; HT_HG-U133A | 6.52e-04 | 197 | 20 | 3 | 5637_UP | |
| Drug | Tamoxifen citrate [54965-24-1]; Down 200; 7uM; MCF7; HT_HG-U133A | 6.52e-04 | 197 | 20 | 3 | 6768_DN | |
| Drug | Mephentermine hemisulfate [1212-72-2]; Up 200; 9.4uM; PC3; HT_HG-U133A | 6.52e-04 | 197 | 20 | 3 | 3685_UP | |
| Drug | Dehydrocholic acid [81-23-2]; Up 200; 9.6uM; PC3; HT_HG-U133A | 6.52e-04 | 197 | 20 | 3 | 4620_UP | |
| Drug | Benfotiamine [22457-89-2]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 6.52e-04 | 197 | 20 | 3 | 3837_DN | |
| Drug | Sertaconazole nitrate [99592-39-9]; Down 200; 8uM; MCF7; HT_HG-U133A | 6.52e-04 | 197 | 20 | 3 | 3550_DN | |
| Drug | Trichlormethiazide [133-67-5]; Up 200; 10.6uM; PC3; HT_HG-U133A | 6.52e-04 | 197 | 20 | 3 | 4198_UP | |
| Drug | Chlorpheniramine maleate [113-92-8]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 6.52e-04 | 197 | 20 | 3 | 6773_DN | |
| Drug | Carbimazole [22232-54-8]; Up 200; 21.4uM; MCF7; HT_HG-U133A | 6.52e-04 | 197 | 20 | 3 | 3299_UP | |
| Disease | adult onset asthma | 5.77e-05 | 118 | 19 | 3 | EFO_1002011 | |
| Disease | Squamous cell carcinoma of lung | 1.93e-04 | 32 | 19 | 2 | C0149782 | |
| Disease | lymphocyte count | 2.29e-04 | 1464 | 19 | 6 | EFO_0004587 | |
| Disease | Charcot-Marie-Tooth disease | 3.33e-04 | 42 | 19 | 2 | cv:C0007959 | |
| Disease | allergic disease | 5.77e-04 | 258 | 19 | 3 | MONDO_0005271 | |
| Disease | monocyte percentage of leukocytes | 1.08e-03 | 731 | 19 | 4 | EFO_0007989 | |
| Disease | autism spectrum disorder, schizophrenia | 1.15e-03 | 327 | 19 | 3 | EFO_0003756, MONDO_0005090 | |
| Disease | eosinophil percentage of leukocytes | 1.16e-03 | 746 | 19 | 4 | EFO_0007991 | |
| Disease | schizophrenia, intelligence, self reported educational attainment | 1.35e-03 | 346 | 19 | 3 | EFO_0004337, EFO_0004784, MONDO_0005090 | |
| Disease | Inhalant adrenergic use measurement | 1.73e-03 | 96 | 19 | 2 | EFO_0009941 | |
| Disease | HIV-1 infection | 1.80e-03 | 98 | 19 | 2 | EFO_0000180 | |
| Disease | attention deficit hyperactivity disorder, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia | 1.91e-03 | 101 | 19 | 2 | EFO_0003756, EFO_0003761, EFO_0003888, MONDO_0004985, MONDO_0005090 | |
| Disease | Glioblastoma Multiforme | 2.30e-03 | 111 | 19 | 2 | C1621958 | |
| Disease | Papillary Renal Cell Carcinoma | 3.04e-03 | 128 | 19 | 2 | C1306837 | |
| Disease | Renal Cell Carcinoma | 3.04e-03 | 128 | 19 | 2 | C0007134 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 3.04e-03 | 128 | 19 | 2 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 3.04e-03 | 128 | 19 | 2 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 3.04e-03 | 128 | 19 | 2 | C1266044 | |
| Disease | stomach cancer (is_marker_for) | 3.73e-03 | 142 | 19 | 2 | DOID:10534 (is_marker_for) | |
| Disease | respiratory system disease | 3.88e-03 | 145 | 19 | 2 | EFO_0000684 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 4.04e-03 | 148 | 19 | 2 | C0279702 | |
| Disease | autism spectrum disorder | 4.48e-03 | 156 | 19 | 2 | EFO_0003756 | |
| Disease | colorectal cancer (is_marker_for) | 4.53e-03 | 157 | 19 | 2 | DOID:9256 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PPPVDCPAPLYELMK | 846 | P21709 | |
| DYMEPEKPGAPLLPP | 546 | Q08345 | |
| PYPMPPLPDEDKKVN | 881 | Q9P0K1 | |
| PKPATDPGLFPMIPD | 211 | P11161 | |
| PPPPEPVPMYSDEDL | 1066 | O60318 | |
| EPGEKVEDMPKPPLP | 681 | P24394 | |
| FMKPLPVPPPVDKDG | 1066 | P51841 | |
| PPDLLPKMPYEPLTP | 376 | Q8IW92 | |
| PDKLYAMPPPGMPEG | 221 | O95718 | |
| LDSPMVSPPPDYPGE | 1056 | A3KN83 | |
| YVQLLEKPGMVPPPP | 56 | O60861 | |
| GPEPIPYPDPALKRE | 1761 | Q8NFP9 | |
| ELPPIEKPVDPPPFM | 541 | Q9P2R6 | |
| AKMPDEPLEPGPLPV | 451 | P25440 | |
| PPYKDLPPKPGTMEE | 31 | Q6ZS10 | |
| PPPMKLPPPYKALTD | 1196 | Q8NI35 | |
| ELPPPEGPLKEPMDL | 371 | Q96BH1 | |
| PQPPPKMGDFYDPEH | 6 | Q9BYW2 | |
| PPPPIPEDIALGKKY | 266 | Q5T200 | |
| QIPGMKIPEPFPLPE | 321 | Q13508 |